Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)

4 Aug 2015

Abstract excerpt

Glioblastoma (GBM) is a highly aggressive primary brain tumor with dismal outcome for affected patients. Because of the significant neo-angiogenesis exhibited by GBMs, anti-angiogenic therapies have been intensively evaluated during the past years. Recent clinical studies were however disappointing, although a subpopulation of patients may benefit from such treatment. We have previously shown that anti-angiogenic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer Research and Treatments
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26243272
DOI: 10.1074/mcp.m115.052423

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)PMID 26243272Read ↗

Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of GlioblastomaSemantic proximity Read ↗

Glioblastoma multiforme: Metabolic differences to peritumoral tissue and IDH-mutated gliomas revealed by mass spectrometry imaging.Semantic proximity Read ↗

Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma CellsSemantic proximity Read ↗

High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates with Lower SurvivalSemantic proximity Read ↗

Cancer- related protein profile of patient-derived and commercial glioblastoma cell lines exposed to TemozolomideSemantic proximity Read ↗

An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by MetforminSemantic proximity Read ↗

The TRiC/CCT Complex at the Crossroads of Metabolism and Hypoxia in GBM: Implications for IDH-Dependent Therapeutic Targeting.Semantic proximity Read ↗

Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.Semantic proximity Read ↗

Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiformeSemantic proximity Read ↗

Anaplerotic nutrient stress drives synergy of angiogenesis inhibitors with therapeutics targeting tumor metabolismSemantic proximity Read ↗

Metabolomic characterization of human glioblastomas and patient plasma: a pilot studySemantic proximity Read ↗

Candidate urine biomarker discovery from only five pairs of samples before and after tumor resection in glioma patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.